[go: up one dir, main page]

PE20120220A1 - Macrolido anti-inflamatorio - Google Patents

Macrolido anti-inflamatorio

Info

Publication number
PE20120220A1
PE20120220A1 PE2011001406A PE2011001406A PE20120220A1 PE 20120220 A1 PE20120220 A1 PE 20120220A1 PE 2011001406 A PE2011001406 A PE 2011001406A PE 2011001406 A PE2011001406 A PE 2011001406A PE 20120220 A1 PE20120220 A1 PE 20120220A1
Authority
PE
Peru
Prior art keywords
theta
grades
peaks
presents
xrpd pattern
Prior art date
Application number
PE2011001406A
Other languages
English (en)
Spanish (es)
Inventor
Caroline Jane Day
Julien Bruno Douillet
Darko Filic
Leanda Jane Kindon
Goran Kragol
Zorica Marusic-Istuk
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41698466&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20120220(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE20120220A1 publication Critical patent/PE20120220A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PE2011001406A 2009-01-30 2010-01-28 Macrolido anti-inflamatorio PE20120220A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14860909P 2009-01-30 2009-01-30

Publications (1)

Publication Number Publication Date
PE20120220A1 true PE20120220A1 (es) 2012-04-04

Family

ID=41698466

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2011001406A PE20120220A1 (es) 2009-01-30 2010-01-28 Macrolido anti-inflamatorio

Country Status (23)

Country Link
US (1) US8227428B2 (fr)
EP (1) EP2384333B1 (fr)
JP (1) JP5437394B2 (fr)
KR (1) KR20110099791A (fr)
CN (1) CN102378763A (fr)
AR (1) AR075340A1 (fr)
AU (1) AU2010209732B2 (fr)
BR (1) BRPI1006114A2 (fr)
CA (1) CA2748847A1 (fr)
CL (1) CL2011001829A1 (fr)
CO (1) CO6400226A2 (fr)
DO (1) DOP2011000242A (fr)
EA (1) EA201101139A1 (fr)
ES (1) ES2412059T3 (fr)
IL (1) IL213871A0 (fr)
MA (1) MA32997B1 (fr)
MX (1) MX2011008074A (fr)
PE (1) PE20120220A1 (fr)
SG (1) SG172782A1 (fr)
TW (1) TW201038277A (fr)
UY (1) UY32408A (fr)
WO (1) WO2010086349A1 (fr)
ZA (1) ZA201104653B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006087644A2 (fr) 2005-01-13 2006-08-24 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Macrolides presentant une activite anti-inflammatoire
WO2010086349A1 (fr) 2009-01-30 2010-08-05 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Macrolide anti-inflammatoire
US20130045939A1 (en) * 2010-03-19 2013-02-21 Catabasis Pharmaceuticals, Inc. Fatty acid macrolide derivatives and their uses
WO2011131749A1 (fr) * 2010-04-23 2011-10-27 Glaxo Group Limited Nouveaux macrolides à 14 et 15 chaînons pour le traitement de maladies inflammatoires à dominance en neutrophiles
JP6116206B2 (ja) * 2012-11-26 2017-04-19 クリニプロ株式会社 吸入用パウダーの製造方法
US20210128699A1 (en) * 2017-01-13 2021-05-06 Tobishi Pharmaceutical Co., Ltd. Neutrophil activation regulator
IL280880B2 (en) 2018-08-27 2025-04-01 Regeneron Pharma Using Raman Spectroscopy in Downstream Purification
PT4118091T (pt) 2020-03-12 2025-08-20 Zoetis Services Llc Ureia azalídeos imunomoduladores

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US525051A (en) 1894-08-28 Adjustable chair
US3725385A (en) 1970-11-02 1973-04-03 Abbott Lab Process for the demethylation of 3-amino macrolides
EP0126344A2 (fr) 1983-05-20 1984-11-28 Abbott Laboratories Esters tripeptidiques d'agents thérapeutiques
PT87417B (pt) * 1987-05-06 1992-08-31 Adir Processo para a preparacao de novos compostos macrolidos
SI9011409A (en) 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
EP0895999A1 (fr) 1997-08-06 1999-02-10 Pfizer Products Inc. Macrolides antibiotiques substitués C"-4
HRP980189B1 (en) 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
ATE392427T1 (de) * 1999-05-18 2008-05-15 Pfizer Prod Inc Neue kristalline formen eines macrolidantibiotikums
HRP20010301A2 (en) 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
AU2003255851B2 (en) 2002-07-08 2009-07-23 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. New compounds, compositions and methods for treatment of inflammatory diseases and conditions
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
GB0310986D0 (en) 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
ES2317527T3 (es) 2005-01-13 2009-04-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Decladinosil-macrolidos que presentan actividad anti-inflamatoria.
WO2006087644A2 (fr) 2005-01-13 2006-08-24 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Macrolides presentant une activite anti-inflammatoire
ATE523519T1 (de) 2005-01-14 2011-09-15 Glaxo Group Ltd Makrolidverbindungen mit biotin und fotoaffinitätsgruppe zur identifizierung eines makrolid-targets
WO2010086349A1 (fr) 2009-01-30 2010-08-05 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Macrolide anti-inflammatoire

Also Published As

Publication number Publication date
US8227428B2 (en) 2012-07-24
AR075340A1 (es) 2011-03-23
ES2412059T3 (es) 2013-07-10
KR20110099791A (ko) 2011-09-08
BRPI1006114A2 (pt) 2018-02-06
EP2384333B1 (fr) 2013-04-17
WO2010086349A1 (fr) 2010-08-05
MA32997B1 (fr) 2012-01-02
JP5437394B2 (ja) 2014-03-12
CA2748847A1 (fr) 2010-08-05
US20100197623A1 (en) 2010-08-05
ZA201104653B (en) 2012-02-29
AU2010209732B2 (en) 2012-12-20
AU2010209732A1 (en) 2011-07-21
JP2012516304A (ja) 2012-07-19
CO6400226A2 (es) 2012-03-15
EP2384333A1 (fr) 2011-11-09
TW201038277A (en) 2010-11-01
CL2011001829A1 (es) 2011-10-14
CN102378763A (zh) 2012-03-14
DOP2011000242A (es) 2011-09-15
SG172782A1 (en) 2011-08-29
UY32408A (es) 2010-07-30
EA201101139A1 (ru) 2012-03-30
IL213871A0 (en) 2011-07-31
MX2011008074A (es) 2011-08-17

Similar Documents

Publication Publication Date Title
PE20120220A1 (es) Macrolido anti-inflamatorio
UA115143C2 (uk) Установка з вироблення сечовини
BR112015014178A2 (pt) compostos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil)carbamimidoil) pirazina-2- carboxamida
AR086745A1 (es) 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
CO6290676A2 (es) Recuperacion de alcoholes superiores a partir de soluciones acuosas diluidas
UY29672A1 (es) Nuevos derivados de pirazina
BRPI0907743A2 (pt) processo para gerar olefinas a partir do etanol
MX341586B (es) Elemento de encofrado.
CU24103B1 (es) Compuestos derivados amido espirocíclicos y sales farmacéuticamente aceptable de los mismos
WO2010088243A3 (fr) Procédés mettant en oeuvre un tamis moléculaire ssz-79
BRPI0809942A2 (pt) Processo de derivados de porfirina, tal como a protoporfirina (ix) e intermediário de síntese
BRPI0814013A2 (pt) material refratário disforme, um processo para a produção de um material refratário disforme de consistência de terra úmida, bem como o uso do material refratário amorfo
NZ709199A (en) Arylalkyl-and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
IN2012DN05035A (fr)
JP2012509241A5 (fr)
WO2010079981A3 (fr) Procédé de purification et de répartition de nanotubes de carbone
TH38164S1 (th) โต๊ะ
TH113152S (th) โต๊ะ
TH141911S (th) ตัวล็อค
TH36557S1 (th) อิฐบล็อค
TH36003S1 (th) อิฐบล็อค
TH111111S (th) อิฐบล็อค
TH111110S (th) อิฐบล็อค
TH902003495A (th) ผ้าดูดฝุ่น 9 มงคล
RU2010130525A (ru) Аморфная форма рокситромицина и способ ее получения

Legal Events

Date Code Title Description
FD Application declared void or lapsed